DTW – How Baylis fits into Boston Scientific’s EP portfolio; also putting Medtech’s story to music

In this episode, Nick Spadea-Anello, Boston Scientific’s global president of electrophysiology, will explain how the $1.7 billion paid for Baylis Medical will help expand the Boston’s extensive EP portfolio. We also talk about the message he likes to impart upon employees of recently acquired companies, sharing some lessons he learned when Boston Scientific acquired his then-employer, Guidant.

We also welcome Brian Johnson, president of MassMedic, the top medical device association in New England, into the booth as our co-host.

Johnson, of course, brings his insider perspective to Newmarker’s Newsmakers, but he also shares how everyone needs to do a better job of sharing medtech’s stories. He should know. Johnson is the co-founder of MassDevice and DeviceTalks! So we got an origin story as well.

Executive editor Chris Newmarker brought a powerful newsmaker list including an interesting take on a recent collaboration between Medtronic and GE Healthcare. Other newsmakers include Alcon, Philips, Abbott, and the deal between Medtronic and Acutus medical that might be an answer to Boston’s acquisition of Baylis.

Alcon SmartCataract study shows enhanced time savings during cataract surgery
DOJ subpoenas Philips over Respironics recall; CEO addresses investigation
Abbott launches upgraded digital health app for neurostimulation
GE Healthcare, Medtronic to collaborate in outpatient care space
Acutus Medical sells left-heart access portfolio to Medtronic in $50M deal